Assignee
G2B PHARMA INC
US·2 granted patents·2 pending applications·47 citations·filing 2013–2020
Top patents by PatentIndex Score
4 records- 0193US9789071B2Intranasal formulation of epinephrine for the treatment of anaphylaxisG2B PHARMA INC·Filed 2013·Granted Oct 17, 2017·41 cites·14 claims
- 0289US10806709B2Intranasal formulation of epinephrine for the treatment of anaphylaxisG2B PHARMA INC·Filed 2017·Granted Oct 20, 2020·6 cites·11 claims
- 0361US2021069126A1Intranasal Formulation of Epinephrine for the Treatment of AnaphylaxisG2B PHARMA INC·Filed 2020·Application pending·0 cites
- 0452US2016220489A1Intranasal Formulation for the Treatment of Cardiopulmonary Resuscitation (CPR), Cardiac Life Support (CLS), Anaphylaxis and/or Anaphylactoid ReactionsG2B PHARMA INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when G2B PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →